Cerca una sperimentazione clinica
Altra/e opzione/i di ricerca
11 Risultato/i
Sperimentazione in fase di reclutamento
= 
; Sperimentazione in corso
= 
; Finanziato da un ente associato a IRDiRC = 
; Membro di una ERN = 
Sperimentazioni cliniche nazionali
GERMANIA
Baden-Württemberg
ULM
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Universitäts- und Rehabilitationskliniken Ulm (RKU)
Klinik für Neurologie
GERMANIA
Bayern
MÜNCHEN
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
LMU Klinikum der Universität München - Campus Großhadern
Institut für Klinische Neuroimmunologie
GERMANIA
Bayern
WÜRZBURG
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Neurologische Klinik und Poliklinik des Universitätsklinikums Würzburg
Neurologische Klinik und Poliklinik
GERMANIA
Berlin
BERLIN
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Charité - Universitätsmedizin Berlin (CCM)
Klinik für Neurologie (CCM)
GERMANIA
Niedersachsen
HANNOVER
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Medizinische Hochschule Hannover
Abteilung Klinische Neuroimmunologie und Neurochemie
GERMANIA
Nordrhein-Westfalen
BOCHUM
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Neurologisches Universtätsklinikum im St. Josef-Hospital
Klinik für Neurologie
GERMANIA
Nordrhein-Westfalen
MÜNSTER
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Universitätsklinikum Münster
Klinik für Neurologie mit Institut für Translationale Neurologie
GERMANIA
Rheinland-Pfalz
MAINZ
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Universitätsmedizin Mainz
Klinik und Poliklinik für Neurologie
GERMANIA
Schleswig-Holstein
KIEL
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Klinik für Neurologie
GERMANIA
Thüringen
JENA
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Universitätsklinikum Jena
Hans-Berger-Klinik für Neurologie
REGNO UNITO; GRAN BRETAGNA
Oxfordshire
OXFORD